Patent ID: 11883383
Assignee: VTV THERAPEUTICS LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 3:
4. A crystalline form of a 4-aminosalicylate salt of [3-(4-{2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-imidazol-4-yl}phenoxy)-propyl]-diethylamine, wherein the crystalline form of is:
a) characterized by at least two of the following features (I-i)-(I-iii):
(I-i) an X-ray Powder Diffraction (XRPD) pattern having peaks at 2θ angles of 17.1°, 19.2°, and 21.5°±0.2°;
(I-ii) a Differential Scanning calorimetry (DSC) profile as shown in FIG. 50; or
(I-iii) a Thermogravimetric Analysis (TGA) profile as shown in FIG. 50; or

b) characterized by at least two of the following features (I-i)-(I-iii):
(I-i) an XRPD pattern having peaks at 2θ angles of 7.1°, 19.2°, and 20.9°±0.2°;
(I-ii) a DSC profile as shown in FIG. 52;
(I-iii) a TGA profile as shown in FIG. 52; or
(I-iv) a 13C Solid-state Nuclear Magnetic Resonance (SSNMR) spectrum as shown in FIG. 69.